Finally, detailed mechanistic characterization of how these drugs restore FOXA2 function may lead to new methods of controlling excessive mucus, lowering bacterial burden and improving the quality of life in patients with chronic lung diseases. Here, FOXA2 is linked to chronic lung disease.